Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	3.95	97.23	93.54
Graham Fair Price	-3.06	2.83	2.92
PEG	517.05	-3.57	0.58
Price/Book	-10.45	3.03	3.38
Price/Cash Flow	75.14	-30.04	-120.83
Prices/Earnings	0.20	29.86	29.80
Price/Sales	9.44	11.53	10.54
Price/FCF	75.14	-30.04	-120.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	23.72	0.29	0.23
Operating Margin	7.51	0.11	0.10
ROA	-10.72	0.01	0.01
ROE	0.03	0.03	-10.62
ROIC	0.03	0.03	-21.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.20	0.83	-76.36
Dividends QOQ	25.99	-0.96	-96.31
EBIT QOQ	0.46	-0.10	-78.85
EPS QOQ	0.51	-0.08	-83.76
FCF QOQ	0.77	-2.69	248.63
Revenue QOQ	0.15	-0.16	5.82
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	165.46	225.34	36.19
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.54	0.40	-26.57
Debt/Capitalization	0.16	0.18	13.72
Quick Ratio	0.42	0.33	-20.45
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	3.65	3.74	2.54
Cash	1.69	1.43	-15.51
Capex	-0.07	-0.07	-1.61
Free Cash Flow	-0.10	-0.38	-269.32
Revenue	1.17	0.98	-16.10
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.55	1.50	-2.98
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-8.36	-5.59	33.16
Naive Interpretation	Member

06 - Financial Health · Weak

Rating